K-numberK242588
Device nameCOREPASS Modular Microcatheter (FLEX); COREPASS Modular Microcatheter (CONTROL)
ApplicantOrbusNeich Medical (Shenzhen) Co., Ltd.
Product codeDQY
Device classClass II
Decision dateJan 7, 2025
DecisionSubstantially Equivalent
Regulation870.1250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The COREPASS Modular Microcatheter (FLEX and CONTROL variants) is a single-lumen catheter designed for use in coronary, peripheral, and abdominal vasculature. It is indicated for supporting and facilitating guidewire placement, exchanging guidewires, and delivering contrast media. The device is offered in two shaft sizes (2.2F and 2.5F) with working lengths of 135 cm or 150 cm.

Technological characteristics

The device shares the same indications, similar catheter design, similar materials of construction, same hydrophilic coating, and same sterilization method as the predicate. Differences include specific materials selected and exact dimensions of components. The catheter is compatible with 0.014-inch guidewires and has a hydrophilic polymer coating on the distal 60 cm.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

The COREPASS device demonstrates substantial equivalence through identical indications for use, similar design architecture, and comparable materials and coating technology as the Teleport XT predicate. Comprehensive performance testing—including sterilization, burst pressure, guidewire compatibility, and biocompatibility assays (cytotoxicity, hemocompatibility, thrombogenicity)—met the same acceptance criteria as the predicate and reference devices, confirming that the minor differences in specific materials and component dimensions do not affect safety or effectiveness for the intended clinical applications.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →